- B97.33 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM B97.33 became effective on October 1, 2022.
- This is the American ICD-10-CM version of B97.33 – other international versions of ICD-10 B97.33 may differ.
ICD-10-CM B97.33 is grouped within Diagnostic Related Group(s):
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to B97.33:
- as cause of disease classified elsewhere > type-1 infection (HTLV-I) B33.3
- T-cell lymphotropic > human B97.35
- type I (HTLV-I) > T-cell lymphotropic B97.33
- T-cell lymphotropic, > human B97.35
- type I (HTLV-I) > T-cell lymphotropic, B97.33
- T-cell lymphotropic, > human B97.35
- type I (HTLV-I) > T-cell lymphotropic, B97.33
- T-cell lymphotropic > human B97.35
- type I (HTLV-I) > T-cell lymphotropic B97.33